Combined sensor and infusion set using separated sites

US9968742B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9968742-B2
Application numberUS-89710607-A
CountryUS
Kind codeB2
Filing dateAug 29, 2007
Priority dateAug 29, 2007
Publication dateMay 15, 2018
Grant dateMay 15, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Embodiments of the invention provide a dual insertion set for supplying a fluid to a body of a patient and for monitoring a body characteristic of the patient. Typical embodiments of the invention include a base, an infusion portion coupled to a first piercing member and a sensor portion coupled to a second piercing member. The infusion portion includes a cannula coupled to the first piercing member for supplying the fluid to a placement site. The sensor portion includes a sensor coupled to and extending from the base having at least one sensor electrode formed on a substrate and is coupled to the second piercing member in a manner that allows the sensor to be inserted at the placement site. The base is arranged to secure the dual insertion set to skin of the patient. Typically the first and second piercing members are arranged such that when the first and second piercing members are operatively coupled to the base, they are disposed in a spatial orientation designed to inhibit sensor interference that may be caused by compounds present in fluids infused through the cannula.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for inhibiting interference of an electrochemical glucose sensor that monitors glucose levels in a patient, wherein the interference is caused by a phenolic preservative present in an insulin infusate infused by an apparatus for supplying a fluid to a body of the patient, the method comprising supplying the fluid to the body of the patient using the apparatus comprising: a base adapted to secure the apparatus to skin of the patient; a first piercing member coupled to and extending from the base, wherein the first piercing member comprises at least one cannula for infusing the fluid to an infusion site, a second piercing member coupled to and extending from the base and including the electrochemical sensor having a sensor electrode for determining the glucose levels of the patient at a sensor placement site, infusion set tubing adapted to connect to the at least one cannula; wherein: the first and second piercing members are disposed on a hub that can operatively engage and disengage from the base; the first and second piercing members are coupled to the base in an orientation such that when the first and second piercing members are inserted into the patient, a first perforation channel made by the first piercing member is not in operable contact with a second perforation channel made by the second piercing member such that the fluid infused to the infusion site cannot flow through the first perforation channel or the second perforation channel to the sensor; and the first and second piercing members are coupled to the base in the orientation such that when the first and second piercing members are inserted into the patient, the sensor and the at least one cannula are separated by at least seven millimeters of tissue; so that the interference is inhibited. 2. The method of claim 1 , wherein the sensor comprises a plurality of layers including: a glucose oxidase layer that detectably alters an electrical current at the electrode in a presence of glucose; and an analyte modulating layer that modulates diffusion of glucose therethrough. 3. The method of claim 1 , wherein the first and second piercing members are inserted into separate in vivo environments. 4. The method of claim 1 , further comprising a medication infusion pump adapted to connect to the infusion set tubing. 5. A method for inhibiting interference of an electrochemical sensor that monitors a body characteristic of a patient, wherein the interference is caused by an interferant present in an infusate infused by an apparatus for supplying a fluid to a body of the patient, the method comprising supplying the fluid to the body of the patient using the apparatus comprising: a base adapted to secure the apparatus to skin of the patient; a first piercing member coupled to and extending from the base, wherein the first piercing member comprises at least one cannula for infusing the fluid to an infusion site, a second piercing member coupled to and extending from the base and including the electrochemical sensor having a sensor electrode for determining the body characteristic of the patient at a sensor placement site, infusion set tubing adapted to connect to the at least one cannula; wherein: the first and second piercing members are disposed on a hub that can operatively engage and disengage from the base; the first and second piercing members are coupled to the base in an orientation such that when the first and second piercing members are inserted into the patient, a first perforation channel made by the first piercing member is not in operable contact with a second perforation channel made by the second piercing member such that the fluid infused to the infusion site cannot flow through the first perforation channel or the second perforation channel to the sensor; the first and second piercing members are coupled to the base in the orientation such that when the first and second piercing members are inserted into the patient, the sensor and the at least one cannula are separated by at least seven millimeters of tissue; and the first and second piercing members are coupled to the base in the orientation so that when the at least one cannula and the sensor are disposed in the patient, the at least one cannula and the sensor function to anchor the apparatus to the skin of the patient; so that the interference is inhibited.

Assignees

Inventors

Classifications

  • with needle insertion means · CPC title

  • invasive, e.g. introduced into the body by a catheter · CPC title

  • for measuring analytes not otherwise provided for, e.g. ions, cytochromes · CPC title

  • for measuring glucose, e.g. by tissue impedance measurement · CPC title

  • electrical or electronic {(A61M5/16804, A61M5/16831 take precedence)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9968742B2 cover?
Embodiments of the invention provide a dual insertion set for supplying a fluid to a body of a patient and for monitoring a body characteristic of the patient. Typical embodiments of the invention include a base, an infusion portion coupled to a first piercing member and a sensor portion coupled to a second piercing member. The infusion portion includes a cannula coupled to the first piercing m…
Who is the assignee on this patent?
Van Antwerp Nannette M, Shah Rajiv, Enegren Bradley J, and 5 more
What technology area does this patent fall under?
Primary CPC classification A61M5/1723. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).